Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection J. ForsterO. MaierH. Werchau Originalia Pages: 407 - 411
Quantitative molecular monitoring of HIV-1 RNA during antiretroviral therapy A. LafeuilladeP. PellegrinoNérina Profizi Originalia Pages: 412 - 418
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: Longitudinal evaluation of six patients under treatment M. ZazziMarinunzia CatucciMaria Rubino Originalia Pages: 419 - 425
A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemicCandida infections in intensive care patients Marianne Abele-HornA. KoppP. Emmerling Originalia Pages: 426 - 432
Procalcitonin in patients with and without immunosuppression and sepsis B. Al-NawasP. M. Shah Brief Report Pages: 434 - 436
High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patients A. P. RiedererG. O. GreinJ. R. Bogner Review Pages: 440 - 446
Clinical development of a new inactivated hepatitis a vaccine E. VidorB. FritzellS. Plotkin Review Pages: 447 - 458
Postantibiotic effect of ceftriaxone and gentamicin alone and in combination onKlebsiella pneumoniae, Pseudomonas aeruginosa andStreptococcus viridans Astrid BuxbaumA. Georgopoulos Experimental Study Pages: 459 - 464
Epidemiology of tick-borne encephalitis virus in Germany M. Roggendorf Special Addendum — Part II Pages: 465 - 466
Neurologic manifestation and classification of borreliosis A. HaassJ. Treib Special Addendum — Part II Pages: 467 - 469
Lyme borreliosis — Problems of serological diagnosis H. Hofmann Special Addendum — Part II Pages: 470 - 472
Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections P. KempfJ. BlumA. Müller Addendum Pages: 473 - 479
Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients P. M. ShahW. StilleC. Lips-Schulte Addendum Pages: 480 - 484